AU Patent

AU1380299A — Use of methylnaltrexone and related compounds

Assigned to Arch Development Corp · Expires 1999-05-24 · 27y expired

What this patent protects

Patent listed against methylnaltrexone-bromide.

Drugs covered by this patent

Patent Metadata

Patent number
AU1380299A
Jurisdiction
AU
Classification
—
Expires
1999-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Arch Development Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.